Vijesti
Vijesti
- Actelion amends its financial reporting schedule
10.04.2017 / 17:35 - GlobeNewswire - Actelion's Annual General Meeting of Shareholders 2017
05.04.2017 / 12:35 - GlobeNewswire - Johnson & Johnson publishes interim result for Actelion tender offer and declares the tender offer successful
31.03.2017 / 07:00 - GlobeNewswire - Actelion issues invitation to 2017 Annual General Meeting of Shareholders
15.03.2017 / 07:00 - GlobeNewswire - Actelion is granted marketing authorization by the European Commission for Ledaga (chlormethine gel) for the treatment of MF-CTCL
07.03.2017 / 07:00 - GlobeNewswire - Actelion obtains "Epoprostenol ACT" label extension for pediatric PAH patients in Japan
02.03.2017 / 07:00 - GlobeNewswire - Johnson & Johnson publishes prospectus for Actelion tender offer
16.02.2017 / 07:00 - GlobeNewswire - Actelion announces excellent financial results for 2016
14.02.2017 / 07:00 - GlobeNewswire - Actelion concludes second line share repurchase program
10.02.2017 / 17:35 - GlobeNewswire - Europe closes lower on Trump's remarks
31.01.2017 / 17:32 - TeleTrader
u realnom vremenu